Skip to: Content | Navigation

PrEP Facts

CDC PrEP Overview
A comprehensive overview – what it is, how it works, who should consider it, how effective it is, and more.

All About PrEP
Basic facts about PrEP – your questions answered.

PrEP Watch

PrEP Watch is a clearinghouse for information on pre-exposure prophylaxis (PrEP) for HIV prevention. It includes information on data, additional research, cost, access and advocacy efforts in the United States and across the globe.

Study Shows 'On-Demand' PrEP to Drastically Reduce HIV Infection

A new study demonstrates that PrEP, or pre-exposure prophylaxis, will significantly reduce HIV transmission if taken immediately before sex.

UNAIDS Welcomes New Indications of Effectiveness of Antiretroviral Therapy in Preventing HIV Among Men Who Have Sex With Men
The data safety and monitoring board for the trial reviewed data for the study and found a “very significant” reduction in the risk of HIV infection in the group of participants using PrEP compared to the placebo group. The monitoring board subsequently recommended that the placebo group be stopped and that all trial participants should be offered PrEP.

Medi-Cal Drops Providing Condoms and HIV Testing as Conditions for Prescribing Truvada

California’s Medi-Cal program has made it easier for low-income people to get access to Truvada.

Truvada for PrEP Medication Assistance Program
The Truvada® for PrEP Medication Assistance Program assists eligible HIV-negative adults in the United States who do not have insurance obtain access to Truvada for PrEP.

New York City Promotes Acceptance of HIV Drug
New York City's health department is advertising on gay hookup apps and lobbying doctors to promote wider use of a controversial anti-HIV pill that vastly cuts the risk of infection. But the therapy has stoked infighting among AIDS activists over promiscuity and safer sex practices.

San Francisco Supervisors allocate money for Truvada Education
The San Francisco Board of Supervisors passed legislation to allocate $301,600 from the city’s general fund toward educating San Francisco residents about the HIV-prevention pill Truvada.